INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$114M

$114,311,628

Total Sells (Filtered)

$0

$0

View Raw Line-Items

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
AKTS P Aktis Oncology, Inc. EcoR1 Capital, LLC • Director Discretionary BuyΔOwn +91.5% 2026-01-12 $39,999,996MEGAx2 View Form 4 →
AKTS	Aktis Oncology, Inc.	EcoR1 Capital, LLC Director Discretionary BuyΔOwn +91.5%	2026-01-12	$39,999,996MEGAx2	P	Form 4
AKTS P Aktis Oncology, Inc. Foley Todd • Director Discretionary Buy 2026-01-12 $4,191,660Large View Form 4 →
AKTS	Aktis Oncology, Inc.	Foley Todd Director Discretionary Buy	2026-01-12	$4,191,660Large	P	Form 4
AKTS P Aktis Oncology, Inc. GADICKE ANSBERT • 10% Owner Discretionary BuyΔOwn +12.2% 2026-01-12 $20,029,986MEGA View Form 4 →
AKTS	Aktis Oncology, Inc.	GADICKE ANSBERT 10% Owner Discretionary BuyΔOwn +12.2%	2026-01-12	$20,029,986MEGA	P	Form 4
AKTS P Aktis Oncology, Inc. Kim Helen Susan • Director Discretionary BuyΔOwn +16.7% 2026-01-12 $15,030,000MEGAx2 View Form 4 →
AKTS	Aktis Oncology, Inc.	Kim Helen Susan Director Discretionary BuyΔOwn +16.7%	2026-01-12	$15,030,000MEGAx2	P	Form 4
AKTS P Aktis Oncology, Inc. MPM BIOVENTURES 2018, L.P. • 10% Owner Discretionary BuyΔOwn +12.2% 2026-01-12 $20,029,986MEGA View Form 4 →
AKTS	Aktis Oncology, Inc.	MPM BIOVENTURES 2018, L.P. 10% Owner Discretionary BuyΔOwn +12.2%	2026-01-12	$20,029,986MEGA	P	Form 4
AKTS P Aktis Oncology, Inc. Vida Ventures II, LLC • 10% Owner Discretionary BuyΔOwn +16.7% 2026-01-12 $15,030,000MEGAx2 View Form 4 →
AKTS	Aktis Oncology, Inc.	Vida Ventures II, LLC 10% Owner Discretionary BuyΔOwn +16.7%	2026-01-12	$15,030,000MEGAx2	P	Form 4